CD276 and triple-negative breast carcinoma: Firstly, B7-H3 affects tumor cell metabolism, as evidenced in triple-negative breast cancer where decreased B7-H3 expression reduces tumor cell glycolytic capacity and increases sensitivity to AKT/mTOR inhibitors [46].